This
post was originally published on
this site
AbbVie has agreed to buy Allergan in a $US63 billion cash-and-stock deal. Allergan shareholders will receive 0.8660 AbbVie shares and $US120.30 in cash for each Allergan share that they hold, totaling $US188.24 per Allergan share.
More »
